Skip to content

SEC Filing Details

Document Details

Form
Filing Date
Jan 2, 2019
Document Date
Dec 28, 2018
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Amarin Corporation plc
copyright
© 2019, Amarin Corporation
Privacy policy  |  Disclaimer
Dublin Office
2 Pembroke House, Upper Pembroke
Street 28-32
Dublin 2, Ireland
US Investor Relations
Amarin Pharma Inc.
1430 Route 206
Bedminster, NJ 07921 USA
Telephone:
+1 908 719 1315
Fax:
+1 908 719 3012

Amarin Corporation